Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sanara MedTech Inc.SMTI · Entity 5880 | Director · Chief Executive Officer | September 15, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sanara MedTech Inc.
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 105,885 |
Reported balance
After 2026-09-15 transaction · row 1
1 source rowRow 1 · 2026-09-15 · Tax withholding · Disposed 3,661 · Balance 105,885 F1: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 9,521 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 9,521 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 20:02 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 3,661 | $35.11 | $128,537.71 |
DisclosureSEC source: 0001493152-26-042898 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,885 F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 9,521 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 9,521 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:02 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 3,852 | $21.06 | $81,123.12 |
DisclosureSEC source: 0001493152-26-024170 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,546 F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 13,466 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 13,466 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| March 22, 2026 Filed Mar 23, 2026 20:32 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 25,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-012179 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,398 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. F1 · price: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 20:02 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 596 | $18.87 | $11,246.52 |
DisclosureSEC source: 0001493152-26-009530 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,968 F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 2,082 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 2,082 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 01:52 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 491 | $20.44 | $10,036.04 |
DisclosureSEC source: 0001493152-26-008596 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,487 F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| March 01, 2026 Filed Mar 10, 2026 00:08 UTC Amendment | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 414 | $20.44 | $8,462.16 |
DisclosureSEC source: 0001493152-26-009406 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,564 F1 · shares: The original Form 4, filed on March 2, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Seth D. Yon (the "Reporting Person"). The original Form 4 mistakenly indicated that the Issuer withheld 491 shares of common stock, when in fact, as reported in this amendment, the Issuer withheld 414 shares of common stock. F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Reporting Person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Reporting Person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · balance_after: The original Form 4, filed on March 2, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Seth D. Yon (the "Reporting Person"). The original Form 4 mistakenly indicated that the Issuer withheld 491 shares of common stock, when in fact, as reported in this amendment, the Issuer withheld 414 shares of common stock. F2 · balance_after: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Reporting Person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:27 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 873 | $19.90 | $17,372.70 |
DisclosureSEC source: 0001493152-26-008341 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,978 F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 3,049 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 3,049 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 20:05 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 28,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-013702 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,851 F1 · shares: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on September 15, 2026, 2027 and 2028, respectively, provided that the reporting person is employed by the Issuer through each such date. F1 · price: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on September 15, 2026, 2027 and 2028, respectively, provided that the reporting person is employed by the Issuer through each such date. Read SEC document |
| May 15, 2025 Filed May 16, 2025 20:15 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 4,929 | $30.88 | $152,207.52 |
DisclosureSEC source: 0001641172-25-011255 · ownership.xml · nonDerivative · entry 1 Yon Seth D · CIK 0002062048 · Pres. & Ch. Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,288 F1 · shares: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 13,465 shares of restricted stock granted to the reporting person on May 15, 2024. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 13,465 shares of restricted stock granted to the reporting person on May 15, 2024. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.